
When we think about insulin resistance, we usually connect it to diabetes or metabolic syndrome. But did you know that elevated insulin levels can also play a role in the development of reproductive cancers? As research continues to unfold, the link between insulin resistance and cancers like breast, ovarian, and endometrial cancer is becoming clearer. Understanding this connection is an important step in protecting your health and lowering your risk.
What Is Insulin Resistance?
Insulin resistance happens when the body’s cells stop responding effectively to insulin, the hormone that regulates blood sugar. To compensate, the body produces more insulin, leading to hyperinsulinemia—chronically high insulin levels. While insulin resistance is often associated with type 2 diabetes, it has much broader effects, especially for women’s health.
How Insulin Resistance Contributes to Cancer Development
Elevated insulin levels can promote cancer development in several ways:
- Increased Cell Growth and Division: Insulin is a growth hormone, and when levels are high, it encourages cells—including cancerous ones—to grow and divide more rapidly. Over time, this unchecked cell proliferation can raise the risk of tumors, particularly in reproductive tissues.
- Higher Levels of Estrogen: Insulin resistance often leads to increased estrogen levels, especially in peri- and postmenopausal women. Since excess estrogen is a known risk factor for breast, ovarian, and endometrial cancers, this creates a concerning cycle. Insulin also lowers levels of sex hormone-binding globulin (SHBG), a protein that regulates estrogen and testosterone. With less SHBG, more of these hormones remain active in the bloodstream, further fueling cancer growth.
- Chronic Inflammation: High insulin levels contribute to chronic, low-grade inflammation. Inflammation damages cells and creates an environment where cancer can thrive. It also weakens the immune system’s ability to detect and destroy abnormal cells before they become a problem.
Reproductive Cancers Linked to Insulin Resistance
Several reproductive cancers have been linked to insulin resistance:
- Breast Cancer: Women with insulin resistance, especially after menopause, face a higher risk of breast cancer. Elevated insulin and estrogen levels can stimulate the growth of cancer cells in breast tissue.
- Ovarian Cancer: Though less common than breast cancer, ovarian cancer has also been connected to insulin resistance. High insulin levels and inflammation may play a role in tumor development and progression.
- Endometrial Cancer: Insulin resistance is strongly associated with endometrial cancer, which affects the lining of the uterus. Excess insulin and estrogen can lead to uncontrolled growth of the endometrium, increasing the chances of cancerous changes.
What You Can Do to Lower Your Risk
The connection between insulin resistance and reproductive cancers is concerning, but the good news is that you have the power to reduce your risk. Here’s how:
- Monitor Your Insulin Levels: Regular insulin testing can help you catch imbalances early. Even if your blood sugar looks normal, elevated insulin can still put you at risk.
- Adopt a Low Insulin Lifestyle: A diet that keeps insulin levels stable can help lower your risk. This means avoiding foods that spike insulin, while focusing on whole, minimally processed foods that are rich in fiber, protein, and healthy fats.
- Exercise Regularly: Physical activity improves insulin sensitivity and helps lower insulin levels. Aim for at least 30 minutes of movement most days each week, whether that’s walking, strength training, or your favorite workout.
Take Charge of Your Health
Understanding the link between insulin resistance and reproductive cancers gives you the power to take action. By managing your insulin levels and making lifestyle changes, you can significantly lower your risk.
At Lilli Health, we provide at-home insulin testing kits and the tools you need to monitor and manage your insulin effectively.
Don’t wait until it’s too late—your health and future are worth taking action now.
References:
- Sun W, et al. Association of insulin resistance with breast, ovarian, endometrial and cervical cancers in non-diabetic women. Am J Cancer Res. 2016. Read more
- Tsujimoto T, et al. Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study. Int J Cancer. 2017. Read more
- Knuppel A, Fensom GK, Watts EL, Gunter MJ, Murphy N, Papier K, Perez-Cornago A, Schmidt JA, Smith Byrne K, Travis RC, Key TJ. Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank. Cancer Res. 2020. Read more